TipRanks
UCB SA (DE:UNC)
XETRA:UNC

Compare UCB SA (UNC) vs. Competitors

41 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€211.90
€38.82B
17.69
-17.63%
3 Buy
2 Hold
0 Sell
Moderate Buy
UCB SA
€221.17
€38.82B
17.69
-17.19%
3 Buy
2 Hold
0 Sell
Moderate Buy
AstraZeneca
12476.00 p
£184.09B
23.42
-4.69%
15 Buy
2 Hold
0 Sell
Strong Buy
GlaxoSmithKline
1905.50 p
£71.31B
14.83
8.04%
2 Buy
10 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1640.00 p
£3.27B
11.68
-13.80%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UNC
UCB SA
203.30
-51.04
-20.07%
GB:0NZT
UCB SA
204.80
-48.56
-19.17%
GB:AZN
AstraZeneca
11,870.00
-642.20
-5.13%
GB:GSK
GlaxoSmithKline
1,779.50
219.04
14.04%
GB:HIK
Hikma Pharmaceuticals
1,580.00
-175.13
-9.98%
GB:INDV
―
―
―
―
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts